Wei et al. reported that treatment of T cells with miR-124 mimic stimulates marked effector immune response including the overexpression of IFN-γ, TNF-α, IL-2, and STAT-3 (as a direct target of miR-124), which mediate immunosuppression in the tumor microenvironment (16). The gene discussed is IL2; the disease is neoplasm.